Buzbuz Capital Corp. and Inolife R&D Inc. have entered into a definitive business combination agreement dated Oct. 1, 2020, whereby Buzbuz will acquire all of the securities of Inolife by way of a three-cornered amalgamation, subject to the terms and conditions of the agreement. For further details on terms of the transaction, please see the company’s press release dated Aug. 7, 2020. The agreement will be filed under Buzbuz’s profile on SEDAR.

Filing statement and caution

Further details about the transaction and the resulting issuer will be provided in the filing statement of Buzbuz to be prepared and filed in respect of the transaction. Investors are cautioned that, except as disclosed in the filing statement, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

Trading in the Buzbuz shares

Trading in the common shares in the capital of Buzbuz will remain halted pending the review of the proposed transaction by the TSX Venture Exchange. There can be no assurance that trading in the Buzbuz shares will resume prior to the completion of the transaction.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.

Chris Brown

Global Capital Markets

Leave a comment